Monday, April 13th 2020.
Rachel brings nearly 30 years’ experience spanning Life Sciences and now the medical devices industry. From start-up through to FTSE100 companies (Amersham Biosciences, Procognia Ltd., Sense Proteomics Ltd. and Oxford Gene Technology), she has played a leading role in product R&D and operational functions, whilst contributing at executive level. Rachel has proven success in people development, change management, project management, R&D manufacturing and quality systems. As CTO of Sky Medical Technology, she has established the company’s technical vision, product roadmaps and all aspects of cost effective technology development. Rachel leads R&D, Clinical Affairs, Quality & Regulatory Affairs, Manufacturing, Logistics and IT .
Rachel, tell us a bit about your background and your projects so far?
My interest and background has always been directed towards medical applications. I have worked in several life science companies from FTSE 50 to SME and a startup where I used my biochemistry and physiology degree as a base to bring molecular research tools to the market for academic research and drug discovery. A deep understanding of medical science together with the ability to appoint and work with multi-disciplinary teams building platform technologies including reagents, equipment and software has stood me in good stead for the last 10 years in medical devices.
I am currently working to deliver a range of wearable medical devices from a platform technology capable of increasing blood circulation which is a valuable benefit for many patient groups including surgical patients, stroke patients and those with chronic wounds.See more